Revista nº 802

175 Juan Daniel Díaz García Linfoma maligno enmascarado REFERENCIAS BIBLIOGRÁFICAS 1. Gerecke C, Fuhrmann S, Strifler S, Schmidt-Hieber M, Einsele H, Knop S. The diagnosis and treatment of multiple myeloma. Dtsch Arztebl Int 2016; 113 (27-28): 470–476. 2. Landgren O, Kyle RA, Pfei er RM, Katzmann JA, Caporaso NE, Hayes RB, et al. Monoclonal gammopathy of undetermined signi cance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood 2009; 113 (22): 5412–17. 3. Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 2014; 15 (12): 538–48. 4. Palumbo A, Anderson K. Multiple myeloma. N Engl J Med 2011; 364 (11): 1046–60. 5. Lones MA, Sanger W, Perkins SL, Madeiros J. Anaplastic large cell lymphoma arising in bone. Report of a case of the monomorphic variant with the t(2;5) (p23;q35) translocation. Arch Pathol Lab Med 2000; 124 (9): 1339-43. 6. Medeiros LJ, Elenitoba J. Anaplastic large cell lymphoma. Am J Clin Pathol 2007; 127 (5): 707-22. 7. Delsol G, Ralfkiaer E, Stein H, Wright D, Jaffe ES. Anaplastic large cell lymphoma. In: World Health Organization Classification of Tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC Press 2001; 94 (7): 230-5. 8. Forteza J, Fraga M. Differential Diagnosis of Classic Hodgkin Lymphoma. Int J Surg Pathol Sup 2010; 18 (3): 124–127. 9. Chor C. Shiu MA, Chi L. Malignant Lymphoma Masquerading as Multiple Myeloma. Leuk Lymphoma 1998; 28(5-6): 607-611. 10. Chen H, Guimin Z, Lianjing W, Huichao Z, Xiaolin W. Simultaneous occurrence of Hodgkin’s lymphoma and multiple myeloma: A case report and review of the literature. Oncol lett 2016; 11 (6): 4139-4143. Figura 3. Inmunohistoquímica: Positividad para los marcadores del linfoma anaplásico EMA y CD30 con expresión en membrana citoplásmica y punto paranuclear, así como ALK-1 en núcleo y citoplasma.